Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

Local biotechnology firms then match public funding ... About 50 miles south of San Francisco in Palo Alto, Stanford is also expanding its biomedical/bioscience research with the “Bio-X ...

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Biotechnology has enormous potential to solve ... Before founding TeselaGen, Mike Fero, Nathan Hillson, and Abeliuk were working at Stanford University, spending a lot of time on tasks that ...

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been its lead cancer-fighting therapy, chop 50% of its workforce and look at ...

Diag-Nose.io hopes to transform management of chronic respiratory diseases globally using its AI-powered biomarker diagnostic ...

Director of the US-Asia Technology Management Center at Stanford University; Marietta Wu, Managing Director of Quan Capital; and Mika Nishimura, Operational Partner of Glide Healthcare. Dr. Kelly ...

Morningstar brands and products Company Portfolio ...